Harvengt J, Lumaka A, Fasquelle C, Caberg J H, Mastouri M, Janssen A, Palmeira L, Bours V
Human Genetics Department, CHU of Liège, Liège, Belgium.
GIGA Research, University of Liège, Liège, Belgium.
Front Genet. 2023 Mar 22;14:1137767. doi: 10.3389/fgene.2023.1137767. eCollection 2023.
ROHHAD syndrome presents a significant resemblance to HIDEA syndrome. The latter is caused by biallelic loss-of-function variants in the gene and encompasses hypotonia, intellectual disabilities, eye abnormalities, hypoventilation, and dysautonomia. We report the first patient identified with HIDEA syndrome from our ROHHAD cohort. Our patient was a 21-month-old girl who had a history of severe respiratory infections requiring intensive care, hypotonia, abnormal eye movements, and rapid weight gain. Polysomnography identified severe central hypoventilation. During her follow-up, a significant psychomotor delay and the absence of language were gradually observed. The prolactin levels were initially increased. Hypothermia was reported at 4 years. Exome sequencing identified a new homozygous truncating variant. Our patient met the diagnosis criteria for ROHHAD, which included rapid weight gain, central hypoventilation appearing after 1.5 years of age, hyperprolactinemia suggesting hypothalamic dysfunction, and autonomic dysfunction manifesting as strabismus and hypothermia. However, she also presented with severe neurodevelopmental delay, which is not a classic feature of ROHHAD syndrome. HIDEA syndrome presents similarities with ROHHAD, including hypoventilation, obesity, and dysautonomia. To date, only 14% of endocrinological disturbances have been reported in HIDEA patients. Better delineation of both syndromes is required to investigate the eventual involvement of , a regulator of calcium dynamics and gliotransmission, in ROHHAD patients. In the case of clinical evidence of ROHHAD in a child with abnormal neurological development or eye abnormalities, we suggest that the gene be systematically interrogated in addition to the analysis of the gene. A better delineation of the natural history of HIDEA is required to allow further comparisons between features of HIDEA and ROHHAD. The clinical similarities could potentially orient some molecular hypotheses in the field of ROHHAD research.
快速进展性肥胖伴下丘脑功能不全、低通气及自主神经功能障碍综合征(ROHHAD综合征)与HIDEA综合征有显著相似之处。后者由该基因的双等位基因功能丧失变异引起,包括肌张力减退、智力残疾、眼部异常、通气不足和自主神经功能障碍。我们报告了首例从我们的ROHHAD队列中确诊为HIDEA综合征的患者。我们的患者是一名21个月大的女孩,有严重呼吸道感染病史,需要重症监护,存在肌张力减退、眼球运动异常和体重快速增加。多导睡眠图检查发现严重的中枢性通气不足。在随访过程中,逐渐观察到明显的精神运动发育迟缓且无语言能力。催乳素水平最初升高。4岁时报告有体温过低。外显子组测序确定了一个新的纯合截短变异。我们的患者符合ROHHAD的诊断标准,包括体重快速增加、1.5岁后出现中枢性通气不足、提示下丘脑功能障碍的高催乳素血症以及表现为斜视和体温过低的自主神经功能障碍。然而,她还出现了严重的神经发育迟缓,这并非ROHHAD综合征的典型特征。HIDEA综合征与ROHHAD有相似之处,包括通气不足、肥胖和自主神经功能障碍。迄今为止,HIDEA患者中仅报告了14%的内分泌紊乱情况。需要对这两种综合征进行更清晰的界定,以研究钙动力学和神经胶质传递调节剂在ROHHAD患者中的最终作用。对于有异常神经发育或眼部异常的儿童出现ROHHAD临床证据的情况,我们建议除了分析该基因外,还应对该基因进行系统检测。需要更清晰地描绘HIDEA的自然病史,以便进一步比较HIDEA和ROHHAD的特征。临床相似性可能会为ROHHAD研究领域的一些分子假说提供方向。